Abraham Ceesay is Chief Executive Officer and Director of Rapport Therapeutics, Inc. (RAPP). The company reported total compensation of $6,265,174 for fiscal year 2025.
| Salary | $652,927 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $5,156,416 |
| Non-equity incentive plan | $431,059 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $24,772 |
| Total | $6,265,174 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Rapport Therapeutics, Inc. filed April 23, 2026, accession 0001193125-26-171828.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and Director | $652,927 | $0 | $0 | $5,156,416 | $431,059 | $0 | $24,772 | $6,265,174 |
| FY2024 | Chief Executive Officer | $576,538 | — | — | $8,947,874 | $293,590 | — | $21,155 | $9,839,157 |
Totals as disclosed in each year's own compensation disclosure for Rapport Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Abraham Ceesay this page | Chief Executive Officer and Director | $6,265,174 |
| Jeffrey Sevigny | Chief Medical Officer | $3,023,942 |
| Troy Ignelzi | Chief Financial Officer | $2,506,139 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Rapport Therapeutics, Inc. compensation brief.
Abraham Ceesay's compensation sits inside Rapport Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.